| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 01/04/2007 | US20070004703 Use of 1-(dialkoxyphenylsulfonyl)-3-(pyrrolidino)-3-(phenyl)indolin-2-one compounds to treat hypertension, cardiovascular disorders, central nervous system disorders, psychological disorders, gastrointestinal disorders; affinity for V1b and V1a receptors of arginine-vasopressin |
| 01/04/2007 | US20070004698 specific activator of retinoic acid receptors subtype beta; 6-[3-adamantan-1-yl-4-(2,2-dimethyl[1,3]dioxoian-4-ylmethoxy)phenyl]naphthalene-2-carboxylic acid; useful in human or veterinary medicine; for body/hair hygiene, treating acne-prone skin, promoting hair regrowth, limiting hair loss, dry skin |
| 01/04/2007 | US20070004659 Method for preventing or delaying the onset of diabetes |
| 01/04/2007 | US20070004650 Endurance improving agent |
| 01/04/2007 | US20070004636 Method of degrading transcriptional factors of saccharometabolism-associated gene, method for inhibiting the degradation, and agent for inhibiting degradation and degradation inhibitor |
| 01/04/2007 | US20070004630 Treating cell proliferation disease; aberrant fetoplacental growth; cancer |
| 01/04/2007 | US20070004619 Relaxin superfamily peptide analogues |
| 01/04/2007 | US20070003614 Pharmaceutical compositions comprising active vitamin D compounds |
| 01/04/2007 | US20070003574 antibody or antiserum directed against a structural protein of Ljungan picornavirus; cardiovascular, nervous system and metabolic disorders; Myocarditis, Cardiomyopathia, Guillain Barre Syndrome, and Diabetes Mellitus, Multiple Sclerosis, Chronic Fatigue Syndrome, Myasthenia Gravis |
| 01/04/2007 | US20070003573 Viral expression vector for use in the treatment and diagnosis of viral, cardiovascular, nervous system and metabolic disorders |
| 01/04/2007 | US20070003556 Modified antibodies against cd22 and utilization thereof |
| 01/04/2007 | US20070003544 Combination therapy for treatment of autoimmune diseases using b- cell depleting/immunoregulatory antibody combination |
| 01/04/2007 | US20070003533 Inhibition of the beta3 subunit of L-type Ca2+ channels |
| 01/04/2007 | US20070003524 Targeted retrograde gene delivery to motor neurons |
| 01/04/2007 | CA2613903A1 Exendin 4 polypeptide fragments and use thereof |
| 01/04/2007 | CA2613522A1 Imidazole based lxr modulators |
| 01/04/2007 | CA2613517A1 Pyrazole based lxr modulators |
| 01/04/2007 | CA2610959A1 Piperidine derivatives useful as histamine h3 antagonists |
| 01/04/2007 | CA2610074A1 6-oxazol-4-ylmethoxy-alkoxymethyl substituted benzoic acid derivatives forming ppar ligands, methods for production and the use thereof in the form of drugs |
| 01/04/2007 | CA2609957A1 Carbon-linked substituted piperidines and derivatives thereof useful as histamine h3 antagonists |
| 01/03/2007 | EP1739087A1 Pyrazole compositions useful as inhibitors of gsk-3 |
| 01/03/2007 | EP1739081A1 Hydrazino-substituted heterocyclic nitrile compounds and use thereof |
| 01/03/2007 | EP1738766A1 Preventive and/or therapeutic agent for disease accompanied by chronic muscle/skeleton pain |
| 01/03/2007 | EP1738762A1 Preventive/remedy for diabetic complications using oligopeptide |
| 01/03/2007 | EP1738755A1 Tablet containing branched chain amino acid and process for producing the same |
| 01/03/2007 | EP1738754A1 Solid pharmaceutical preparation |
| 01/03/2007 | EP1738753A2 New treatments using phenethylamine derivatives |
| 01/03/2007 | EP1738751A2 Spaced drug delivery system |
| 01/03/2007 | EP1738658A1 Acerola leaf extract-containing blood sugar level increase inhibitor and age formation inhibitor, and food containing them |
| 01/03/2007 | EP1737864A1 Selected cgrp antagonists, methods for the production thereof, and use thereof as medicaments |
| 01/03/2007 | EP1737863A2 2-cyanopyrrolidinecarboxamides as dipeptidyl peptidase-iv inhibitors |
| 01/03/2007 | EP1737845A2 Disalt inhibitors of il-12 production |
| 01/03/2007 | EP1737839A1 Novel alkyne compounds having an mch-antagonistic effect and medicaments containing said compounds |
| 01/03/2007 | EP1737824A2 Novel alkyne compounds having an mch-antagonistic effect, and medicaments containing said compounds |
| 01/03/2007 | EP1737823A2 Novel alkyne compounds with an mch-antagonistic action and medicaments comprising said compounds |
| 01/03/2007 | EP1737809A2 Compounds, pharmaceutical compositions and methods for use in treating metabolic disorders |
| 01/03/2007 | EP1737460A2 Intermittent dosing regimen for the treatment of overweight with mtp-inhibitors |
| 01/03/2007 | EP1641466B1 2-methylene-19-nor-20(s)-25-methyl-1alpha-hydroxycalciferol and its uses |
| 01/03/2007 | EP1562925B1 Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 01/03/2007 | EP1517619B1 Satiety inducing composition |
| 01/03/2007 | EP1406507B1 Methods of extracting casein fractions from milk and caseinates and production of novel products |
| 01/03/2007 | EP1390403B1 Peptides derived from neural thread proteins and their medical use |
| 01/03/2007 | EP1363615B1 Preservation of body protein |
| 01/03/2007 | EP1328319B1 7-amino-2-alkylthiopteridin-4-yl-amines for the treatment of chemokine-related diseases |
| 01/03/2007 | EP1322176B1 Use of carnitine for enhancing training-induced bradycardia |
| 01/03/2007 | EP1265907B1 Novel aryl fructose-1,6-bisphosphatase inhibitors |
| 01/03/2007 | EP1221865B1 Food supplement for increasing lean mass and strength |
| 01/03/2007 | EP1212071B1 Stable carotene-xanthophyll beadlet compositions and methods of use |
| 01/03/2007 | EP0871474B1 Generation of human insulin |
| 01/03/2007 | CN1890236A Novel thiazole derivates |
| 01/03/2007 | CN1890219A Benzoyl amino pyridyl carboxylic acid derivatives useful as glucokinase (GLK) activators |
| 01/03/2007 | CN1890217A N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprotein B |
| 01/03/2007 | CN1890214A Heterocyclic- or aryloxy, -thio or -amino substituted indoles-2-carboxylic acids or esters as pai-1 |
| 01/03/2007 | CN1889948A Use of organic compounds |
| 01/03/2007 | CN1887906A Hypoglycemic polypeptide from silkworm and its prepn and use |
| 01/03/2007 | CN1887882A Dextro lipoic amidate and its prepn |
| 01/03/2007 | CN1887306A Active bitter gourd soft capsule and its prepn |
| 01/03/2007 | CN1887298A Prepn process of oyster polysaccharide-mucleic acid-nanometer calcium composition |
| 01/03/2007 | CN1887293A Slimming composition with cross-linked monosaccharide/disaccharide and dietary fiber |
| 01/03/2007 | CN1887277A Dispersant tablet containing hypolipidemic component and its prepn process |
| 01/03/2007 | CN1887101A Slimming tea and its prepn |
| 01/03/2007 | CN1293187C Acid and choline-resistant separated strain of lactobacillus with ability of reducing and assimilating cholesterol |
| 01/03/2007 | CN1293186C Acid and choline-resistant separated strain of lactobacoillus with ability of reducing and assimilating cholesterol |
| 01/03/2007 | CN1293185C Acid and choline-resistant separated strain of lactobacillus with ability of reducing and assimilating cholesterol |
| 01/03/2007 | CN1293087C Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same |
| 01/03/2007 | CN1293076C Activator for peroxisome proliferator-activated receptor delta |
| 01/03/2007 | CN1293072C Heterocyclyloxy-thioxy-and-aminobenzazole derivatives as 5-hydroxytryptamine-6 ligands |
| 01/03/2007 | CN1293044C Substituted phenypropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor alpha (PPAR) |
| 01/03/2007 | CN1293034C New gamma selective retinoids |
| 01/03/2007 | CN1292790C Chinese traditional medicine for preventing and curing cardiovascular and cerebrovascular diseases |
| 01/03/2007 | CN1292756C Effervescence tablet preparation for replenishing nutritious elements to human being and its preparation method |
| 01/03/2007 | CN1292736C Dripping pill made from haw, chrysanthemum and Chinese wolfberry fruit and its preparing method |
| 01/02/2007 | US7157604 Selective estrogen receptor modulators |
| 01/02/2007 | US7157584 Benzimidazole derivative and use thereof |
| 01/02/2007 | US7157580 Aminopyrimidine and aminopyridine anti-inflammation agents |
| 01/02/2007 | US7157578 4-(2-butylamino)-2, 7-dimethyl-8-(2-methyl-6-methoxypyrid-3-YL) pyrazolo-[1,5-A]-1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligands |
| 01/02/2007 | US7157569 Comprises nucleotide sequences coding gamma aminobutyric acid type A (GABAA) receptor for diagnosis and treatment of brain, anxiety, depressive, nervous system, migraine and/or obesity disorders |
| 01/02/2007 | US7157490 Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 01/02/2007 | US7157487 Vla-4 inhibitors |
| 01/02/2007 | US7157479 Oxazol/thiazol-derivatives activators of the hPPAR-alpha receptor |
| 01/02/2007 | US7157472 N-alkylpiperdino-4-yl-urea-pyrazole derivative for treating obesity, metabolic disorders, eating disorders and diabetes |
| 01/02/2007 | US7157469 For therapy of immune related responses, tumor growth, glomerulonephritis, inflammation, malarial anemia, septic shock, tumor associated angiogenesis, vitreoretinopathy, psoriasis, graft versus host disease, atopic dermatitis |
| 01/02/2007 | US7157463 Substituted piperidines/piperazines as melanocortin receptor agonists |
| 01/02/2007 | US7157457 Compounds useful in the treatment of inflammatory diseases |
| 01/02/2007 | US7157454 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same |
| 01/02/2007 | US7157451 Cardiac arrhythmias; potassium channel function inhibitors; such as 7-(3,4-Dichlorophenyl)-6-(5-fluoro-1-methyl-1H-benzimidazol-2-yl)-4,7 -dihydro-5-(methoxymethyl)pyrazolo-(1,5-a)pyrimidine |
| 01/02/2007 | US7157425 Apolipoprotein agonist for use in the treatment of dyslipidemia |
| 01/02/2007 | US7157423 Using fumaric acid mono- and diamides, or monoamido fumaric acid monoesters for therapy of an autoimmune disease; transplantation medicine; therapy of mitochondrial diseases, for therapy of NF-kappaB mediated diseases |
| 01/02/2007 | US7157420 Therapeutic agents and methods of use thereof for the modulation of angiogenesis |
| 01/02/2007 | US7157241 Dipeptidyl peptidase IV (DPPIV); given sequences; homology with family of prolyl oligopeptidases; drug screening for enzyme inhibitors for DPPIV which could treat reproductive, inflammatory and metabolic disorders |
| 01/02/2007 | US7157240 MID 4460, a human tyrosine phosphatase family member and uses therefor |
| 01/02/2007 | CA2400226C Method for the improvement of islet signaling in diabetes mellitus and for its prevention |
| 01/02/2007 | CA2344350C 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines |
| 01/02/2007 | CA2328320C Encapsulated long chain alcohols |
| 01/02/2007 | CA2218892C Diaromatic propynyl or dienyl compounds |
| 01/02/2007 | CA2191454C Phosphinic acid derivatives and their use as endothelin converting enzyme inhibitors |
| 01/02/2007 | CA2174517C Receptor specific atrial natriuretic peptides |
| 12/29/2006 | CA2549477A1 Competitive regulation of hepcidin mrna by soluble and cell-associated hemojuvelin |
| 12/28/2006 | WO2006138734A1 Triazolopyrimidine cannabinoid receptor 1 antagonists |
| 12/28/2006 | WO2006138682A1 Azabicyclic heterocycles as cannabinoid receptor modulators |